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PREVENTION AND CONTROL OF TRICHOMONIASIS
William G. Kvasnicka
School of Veterinaxy Medicine
College of Agriculture
University of Nevada, Reno
Reno NV 89557
INTRODUCTION
Weather, nutrition, public land policy, marketing options, and diseases all influence the
sustainability and profitability of cow-calf enterprises in the United States. One of the diseases is
trichomoniasis. It is a venereal disease of cattle causing reproductive failure and considerable
economic loss in areas of the world where natural breeding is used.(1,2) The disease is one of the
most common infectious diseases causing decreased reproductive efficiency in beef cattle in the
western United States.(1)
THE DISEASE
The cause of bovine trichomoniasis is the protozoan parasite Tritrichomonas foetus. The
disease, venereally transmitted, results in infertility and includes early embryonic death, abortion
and pyometra.(3) Most abortions occur during the first half of gestation starting 45 days after
conception. A few abortions occur as late as the 7th month.(3,4) Persistence of infection follows
normal parturition in some cows.(5,6)
In bulls T. foetus is found only on the penis and the preputial membranes. It causes no
lesions of diagnostic significance. The infected bull serves only as a carrier of the organism.(5)
Older bulls tend to become permanent carriers. The increased number and depth of the crypts in
the epithelial lining of older bulls contributes to the persistence of infection.(7)
In cows T. foetus colonizes the vagina, uterus, and oviduct but does not prevent
conception.(8) The secretions from these organs contains the parasite. The only observable
symptoms are a mild vaginitis and endometritis. The inflammatory response of the uterus occurs
1 1/2 to 2 months after infection by the bull and may be responsible for embryonic wastage.
Some cows develop a natural immunity and will conceive and carry a calf to term after three to
five heat cycles following abortion. That immunity is not permanent and the cow is subject to
reinfection in subsequent breeding periods.(8)
DIAGNOSIS AND PREVALENCE
Herd history and culture of prepucial smegrna or cervical-vaginal mucus aid the
veterinarian in making a field diagnosis.(9) Culturing identifies carrier bulls and infected cows
but the procedure has repeated sensitivities of 81% to 97%. Thus bulls must be tested three times
and heifers five times to assure diagnostic reliability.(10) The organism can be obtained from
animals with pyometra or from abomasal contents of fetuses aborted due to trichomoniasis.(11)

Researchers find consistent patterns of placental and fetal lesions due to T. foetus. Recognition of
these changes indicate diagnosis of trichomoniasis abortion if proper specimens are not available
for culture.(12)
Another diagnostic aid which has recently been developed is the nucleic acid probe (ABI
Trich Test - Amipro). Probes should be highly sensitive and specific since they detect specific
genetic sequences. Materials for nucleic acid testing do not need to contain living cells or
parasites and careful treatment of diagnostic samples is not critical.(13)
An additional diagnostic tool that improves the convenience of testing for trichomoniasis
is a system which consists of a small, clear plastic pouch veterinarians use to collect, store, and
examine culture specimens for the protozoa. This system is commercially available (In Pouch TF
- Bio Med Diagnostics, Inc.).( 14)
Infection rates for bovine trichomoniasis vary from 5% to 50%. Idaho regulations require
all bulls to be tested for trichomoniasis.(16) The results of Idaho testing indicate that 5.5% to 3%
of all herds tested in 1990 and 1991 were infected and the rate of infection within a herd was
10%.(17) It has been found that from 3.25% to 34.6% of bulls in infected herds were infected
with T. foetus.(2,18) Infection rates of this magnitude will decrease calf production from 7.6% to
28.6%. (2) Herd infection rates of 30% to 46% have been reported in Nevada.(15) In herds with
20% to 40% of the bulls infected with T. foetus, a reduction of 14% to 50% in annual calf crop
occurs and the calving season is prolonged.( 19)
CONTROL
Veterinarians and producers have devised control methods based on a general knowledge
of how the disease organism is introduced, spreads, and is perpetuated in a herd of cattle.
Although the recommendations are sometimes successful, the increase in the disease, especially
in the western United States indicates that they are not uniformly successful.(1) The failure of
these methods can be traced to several causes:(13)
1. Lack of compliance for testing.
2. Reluctance to test when producers are experiencing drought and a lack of nutritional
resources.
3. Animal movements throughout the United States.
4. A lack of a reliable and sensitive diagnostic test.
5. The practice of grazing beef herds in common on public lands.
6. Lack of a safe and effective cow her vaccine.
A vaccine, by raising the resistance of the breeding female and protecting against loss
should enhance T. foetus control programs. Vaccines are now available to control
Trichomoniasis (Trich Guard - Fort Dodge Laboratories). (15-20) The vaccine protects against
abortion by shortening the time a cow is infected following challenge. The resulting protection
increases the percentage calf crop by up to 97.1% and shortens the calving season. The vaccine is
administered to the cow herd yearly before the breeding season. Two shots are required the first

year to raise the resistance of the breeding herds. In subsequent years the replacement heifers will
require two injections of the vaccine and the cows an annual booster.
An effective control program includes the following management practices. These
recommendations are based on an understanding of how the disease is spread and on the
availability of a safe and effective vaccine that protects the cow herd against the infection and
abortion caused by Trichomonas foetus.(21)
• Vaccinate the cow herd yearly before the breeding season.
• Maintain as young a bull battery as possible.
• Culture bulls a month after the breeding season and sell the positives.
• Culture all new bulls purchased.
• Breed virgin bulls to virgin heifers.
• Pregnancy test all cows and heifers 60 days after breeding and cull open females.
• Sell any cows that fail to calve during the subsequent calving season.
• Have fences in good repair to keep stray animals out.
• Don’t purchase cull cows.
• Do not use loaner bulls.
• Do not lease bulls.
TRICHOMONIASIS VACCINE DEVELOPMENT AND EFFICACY TRIALS
As early as 1947, scientists were attempting to develop vaccines for bovine
trichomoniasis.(22) In 1983 an experimental vaccine developed by Australian researchers
showed that the age at which a bull becomes permanently infected can be delayed by
approximately one year.(23) Their vaccine was also effective in clearing T. foetus from bulls less
than five years of age. Vaccination of bulls older than five years was ineffective.(24)
study of T. foetus isolates from diverse areas of the United States revealed few
differences in the antigen profiles identified.(25) Thus it appeared feasible to prepare a vaccine
from a single pathogenic strain of T. foetus and evaluate the resulting immunogenicity and
protection against T. foetus induced fetal wastage.
Corbeil demonstrated that mucosal surface reactive antibodies not only agglutinate and
immobilize T. foetus but also inhibit its adherence to vaginal epithelial cells.(26) All three of
these protective functions provide evidence that systemic immunization with T. foetus antigens
would protect the bovine reproductive tract against trichomoniasis.
In an immunogenicity trial reported by Schnackel, few or no injection site or systemic
reactions occurred. The immunity induced by the vaccine also prevented or greatly reduced T.
foetus infection following challenge.(20)
A trial at the University of Nevada, Reno to determine the immunogenicity of a bovine
Trichomonas foetus vaccine and the ensuing protection against fetal wastage following challenge
was initiated in 1989. Ninety beef heifers from a single source, known to be free of T. foetus,

were randomly assigned to two groups. The groups were designated control and mono. The mono
group received two doses, three weeks apart, of a Trichomonas foetus vaccine administered
subcutaneously. Each two ml dose of the vaccine contained 5x10 (7) inactivated organisms,
along with a Fort Dodge proprietary adjuvant.
On the same vaccination dates, but at separate injection sites, Campylobacter fetus,
Clostridium eight way, Leptospirosis-5, H. somnus, killed IBR-BVD and PI-3 vaccines were
administered to the mono and control groups. Serum samples were collected from heifers prior to
initial vaccination. Additional serum samples were collected 21 days after first vaccination, 28
after second vaccination, 45 days after challenge, and whenever a heifer was eliminated from the
study. (Heifers were eliminated at the time of abortion, or at calving.)
Breeding started thirty days after the second vaccinations. The heifers were bred to eight
T. foetus infected bulls purchased from Nevada and California ranchers. All bulls used in the
trial had received a satisfactory breeding soundness evaluation. The bulls were monitored
throughout the forty five day breeding period to assure infectivity. In addition all heifers were
infused vaginally with 1 x10 (7) T. foetus organisms within 18 hours of the time estrus was
observed.
Thirty five percent of each group was subjected to cervical mucus culture eighteen days
after challenge to determine infectivity and to measure protection against infection. Conception
was determined by rectal palpation 60 days after breeding. Abortion was detected by rectal
palpation every 30 days. Chi-square analysis of variance was used for data analysis.
The reciprocal geometric mean indirect fluorescent antibody titers for the mono group
was less than 5 before vaccination, 992 at time of second vaccination and 1,731 twenty eight
days post second vaccination. Titers for the control group were less than five for all three
samples.
Cervical cultures were 57% positive (N =14) for the mono group and 76% positive (N=
17) for the controls.
Conception rate was 72.5% (N =40) for the mono group and 84.1% (N=44) for the
controls.
The abortion rate was 17.2% (N=29) for the mono group and 39.4% (N= 38) for the
controls.(Graph 1) This represents a reduction in abortion of 56.4%.
Another immunogenicity trial was initiated in 1990. The materials and methods for the
1990 trial were similar to the 1989 trial except the control group received Campylobacter
fetus-Leptospira canicola grippotyphosa hardjo icterohaemorrhagiae pomona bacterin and the
vaccine group received the latter bacterin containing 5 x 10 (8) T. foetus vaccine at 3 week
intervals. The heifers were bred to naturally infected bulls and no additional T. foetus
intravaginal infusion challenge was imposed. However an additional challenge was provided by
infusion of each bull at the start and again upon completion of a five day breeding cycle. Two

groups of six bulls were used to breed the heifers and they were exchanged every five days. The
initial determination of conception for each heifer was performed utilizing the pregnancy specific
protein B method.(27)
Following vaccination and prior to challenge by breeding with infected bulls,
cervico/vaginal mucus samples were collected for culture of T. foetus. All heifers were culture
negative at that time. To assess the ability of the vaccine to prevent infection, ten control and ten
vaccinate animals were randomly selected from the test herd and mucus samples for T. foetus
culture were collected for 18 weeks following the 45 day breeding cycle. The vaccine appeared to
exhibit significant efficacy in preventing infection and in shortening the duration of infection.
One week after challenge, 60% of vaccinates were culture positive compared with 80% of
controls. The average duration of infection of vaccinates was 3.8 weeks compared to 5.4 weeks
of infection for control heifers.
The thirty day pregnancy detection assay showed that 89.2% (58 of 65 heifers) of
vaccinates and 85.9% (55 of 64 heifers) of control animals were pregnant. From 60 to 210 days
post breeding heifers were examined by palpation at 30 day intervals. Sixty days post breeding,
82% of control and 86% of the vaccinated animals that conceived remained pregnant. Within the
next four months the pregnancy rate of control heifers declined to 31% of those that conceived.
In the same four month period, over 60% of the vaccinated animals remained pregnant.
Significantly, over 62% of heifers vaccinated against T. foetus infection produced calves while
only 31% of control heifers bore calves.
These results indicate that the monovalent bovine Trichomonas foetus test vaccine used
reduced the fetal wastage attributed to T. foetus infection. This is especially significant in light of
the overwhelming challenge attained by the natural breeding of each heifer assigned to the trial to
an infected bull, plus the vaginal infusion of live T. foetus parasites shortly following observed
estrus.
It is not clear how the systemic antibody titers induced by the vaccine reduces T. foetus
infectivity and protects against abortion. Systemic vaccination does stimulate local antibody
response.(27) Reports demonstrate increased local anti-trichomonal antibodies in the
reproductive tract secretions of infected heifers.(28)
Other studies show that anti-T. foetus antibodies enhanced the killing of the parasite by
the alternate bovine complement pathway(29) and prevented adherence of T. foetus to bovine
epithelial cells.(26) It appears that vaccine-produced-antibodies may effectively limit T. foetus
infectivity. The reduction or elimination of the parasite prior to its ability to cause abortion
apparently reduces the fetal wastage associated with bovine Trichomoniasis.
CONCLUSIONS
Closed herds and strict management control can eliminate Trichomoniasis. These
approaches do not seem to be feasible for extensively managed beef herds. In any herd, a bull
oriented approach to control will probably be ineffective since a small number of animals escape

detection. The carrier cow syndrome will likely continue to perpetuate the disease in infected
herds. The chronically infected bull and the carrier cow will continue to threaten non-infected
herds. A few infected animals can eventually lead to a large number of infected cows. The
associated reproductive inefficiency will reduce the profitability of the cow-calf operation.
Current control strategies effectively lower the challenge in T. foetus infected herds;
however, they do not totally eliminate the infection. The results being reported from carefully
controlled studies demonstrate that a bovine trichomoniasis vaccine does raise the cow herd’s
resistance and reduces the fetal wastage associated with infection. In infected herds, or herds
threatened by infection, current control strategies to lower the challenge should be combined with
a vaccination program to raise the resistance to Trichomonas foetus. This will effectively reduce
the abortion rate, shorten the calving season, and improve cow-calf ranching profitability.
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